Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Injured myocardium, specifically necrotic myocardial cells, refers to heart muscle tissue that has undergone irreversible cell death due to acute injury—most commonly from ischemia (lack of blood flow and oxygen). This process is central in conditions such as myocardial infarction (heart attack), where a critical loss of perfusion leads to the death of cardiomyocytes. Necrotic cardiomyocytes lose membrane integrity, causing leakage of intracellular components into the extracellular space. This underlies clinical biomarkers for myocardial infarction diagnosis. The predominant form is coagulation necrosis: affected cells become acidophilic with preserved outlines but altered internal structure. Leukocyte infiltration follows as part of an inflammatory response. Necrotic myocardium triggers robust inflammation aimed at clearing dead cells and initiating repair.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Injured Myocardium (Necrotic Myocardial Cells).